Article
Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling.
Current biology : CB - 20 Aug 2002
Fan Qi-Wen, Zhang Chao, Shokat Kevan M, Weiss William A
Abstract excerpt
BACKGROUND: Our understanding of protein kinase inhibition in the treatment of cancer is clearly limited by the lack of inhibitors that selectively block a single kinase implicated in neoplastic transformation. One approach to developing specific inhibitors is to engineer in protein kinases silent mutations that allow selective inhibition while retaining kinase activity. Because it is implicated in a large number...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
